Civil society participation in global public private partnerships for health
Datos Bibliográficos
| ID | 11490106 |
|---|---|
| Autores | Katerini T Storeng (0000-0003-0032-7006, University of Oslo, autor de correspondencia), Antoine de Bengy Puyvallée (0000-0002-5800-3701, University of Oslo) |
| Año | 2018 |
| Volumen | 33 |
| Número | 8 |
| Páginas | 928-936 |
| Fecha de publicación | 2018-10-01 |
| Peer Reviewed | Sí |
| Open Access | Sí |
| Tipo | ARTICLE |
| Revista | Health Policy and Planning (JOURNAL) |
| Identificadores de la revista | ISSN: 0268-1080 • E-ISSN: 1460-2237 |
| Editorial | Oxford University Press (PUBLISHER • GB) |
| DOI | 10.1093/heapol/czy070 |
| PMID | 30165606 |
| OpenAlex | W2889467997 |
| Idioma | EN |
| Citas recibidas | 20 |
| Referencias citadas | 33 |
The growth of global public-private partnerships for health has opened up new spaces for civil society participation in global health governance. Such participation is often justified by the claim that civil society organizations, because of their independence and links to communities, can help address democratic deficits in global-level decision-making processes. This article examines the notion of 'civil society engagement' within major public-private partnerships for health, where civil society is often said to play a particularly important role in mediating between public and private spheres. How do major global health partnerships actually define 'civil society', who represents civil society within their global-level decision-making bodies, and what formal power do civil society representatives hold relative to other public and private-sector partners? Based on a structured analysis of publicly available documents of 18 of the largest global public-private partnerships for health, we show that many of them make laudatory claims about the value of their 'civil society engagement'. Most use the term 'civil society' to refer to non-governmental organizations and communities affected by particular health issues, and state that they expect these actors to represent the needs and interests of specific populations in global-level decisions about strategies, funding models and policies. Yet, such civil society actors have a relatively low level of representation within the partnerships' boards and steering committees, especially compared with private-sector actors (10.3 vs 23.7%). Moreover, there is little evidence of civil society representatives' direct and substantial influence within the partnerships' global-level governing bodies, where many decisions affecting country-level programmes are made. Rather, their main role within these partnerships seems to be to implement projects and advocate and raise funds, despite common discourses that emphasise civil society's watchdog function and transformative power. The findings suggest the need for in-depth research into the formal and informal power of civil society within global health governance processes.
Civil society · Corporate governance · Democracy · Economics · Global health · Health care · Management · Political science · Politics · Private sector · Public health · Public relations · State (computer science) · Global Health and Surgery · Global Maternal and Child Health · Global Public Health Policies and Epidemiology · Law · Medicine · Public Administration
Risky business
Power in Global Nutrition Governance
Aligning rhetoric with reality
NGOs and Global Business Regulation of Transnational Alcohol and Ultra-Processed Food Industries
The rising authority and agency of public–private partnerships in global health governance
Government-NGO relationship
Civil society and perilous medicine in Africa
Rethinking international financing for health to better respond to future pandemics
Responsible Accountability? Multi‐Stakeholder Partnerships, Sustainable Development and Global Health
Efficacy of civil society organizations to mitigate gender-based sexual violence in schools, in Liberia
Covax and the rise of the ‘super public private partnership’ for global health
The role of civil society organizations (CSOs) in the Covid-19 response across the Global South
The Gates Foundation’s network diplomacy in European donor countries
Covax, vaccine donations and the politics of global vaccine inequity
The landscape of public-private partnerships in global health governance
Unwrapping the Global Financing Facility
Impacts of Covid-19 in the Commonwealth Caribbean
Civil society priorities for global health
Power across the global health landscape
The impact of Ingo ties on flows of aid for women’s health in the developing world
Building Global Democracy?
Philanthrocapitalism, past and present
Can NGOs Make a Difference
Adventures in Aidland
Evaluating Transnational NGOs
Globalization
Improving preventive health care in Aboriginal and Torres Strait Islander primary care settings
Gender blind? An analysis of global public-private partnerships for health
Civil society
Addressing the intersection between alcohol consumption and antiretroviral treatment
The multiple meanings of global health governance
Meaningful change or more of the same? The Global Fund's new funding model and the politics of HIV scale-up
The stages of international (global) health
The Global Fund and the re-configuration and re-emergence of ‘civil society’
The Gavi Alliance and the ‘Gates approach’ to health system strengthening
Has Global Fund support for civil society advocacy in the Former Soviet Union established meaningful engagement or 'a lot of jabber about nothing
Lives in the balance”
Post-Accra
The World Health Organization and the Transition From “International” to “Global” Public Health
Integrated Deliberation
Civil Society and Democratically Accountable Global Governance
Democracy in Global Governance
Seven habits of highly effective global public-private health partnerships
Civil society organisations and global health initiatives
Circus monkeys or change agents? Civil society advocacy for HIV/Aids in adverse policy environments
What the word 'partnership' conjoins, and what it does
Outsourcing Social Transformation
| Obras citantes distintas | 20 |
|---|---|
| Citas por año | 2,86 |
| Intervalo de citas | 2019 - 2026 (8) |
| Velocidad de citación | current |
| Altamente citado | No |
| Tipos de cita | Neutras: 18 |